Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury

Journal of Neurotrauma

Volumn 24, Issue 5, 2007, Pages 772-789

  Opii, Wycliffe O ^a   Nukala, Vidya N ^b   Sultana, Rukhsana ^a   Pandya, Jignesh D ^b   Day, Kristen M ^b   Merchant, Michael L ^c   Klein, Jon B ^c   Sullivan, Patrick G ^b   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

Controlled cortical impact; Mitochondria; Oxidative stress; Proteomics; Reactive oxygen species; Traumatic brain injury

Indexed keywords

CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE VA; ENOLASE; ENOLASE 1; FUMARATE HYDRATASE; FUMARATE HYDRATASE 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; ISOVALERYL COENZYME A DEHYDROGENASE; MITOCHONDRIAL PROTEIN; PROHIBITIN; PROTEIN DERIVATIVE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; BRAIN CORTEX; CELL DEATH; ENERGY TRANSFER; ENZYME ACTIVITY; HIPPOCAMPUS; INTROSPECTION; MALE; NONHUMAN; OXIDATION; PROTEIN ANALYSIS; PROTEOMICS; RAT; SPRAGUE DAWLEY RAT; TRAUMATIC BRAIN INJURY;

ADENOSINE TRIPHOSPHATE; ANIMALS; BRAIN; BRAIN INJURIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; ENZYMES; HIPPOCAMPUS; MALE; MITOCHONDRIAL PROTEINS; NERVE DEGENERATION; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 34249096439     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2006.0229     Document Type: Article

References (92)

1. AKSENOVA, M., BUTTERFIELD, D.A., ZHANG, S.X., et al. (2002). Increased protein oxidation and decreased creatine kinase BB expression and activity after spinal cord contusion injury. J. Neurotrauma 19, 491-502.
2. AZOULAY-ZOHAR, H., ISRAELSON, A., ABU-HAMAD, S., et al. (2004). In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem. J. 377, 347-355.
3. BALDWIN, S.A., and SCHEFF, S.W. (1996). Intermediate filament change in astrocytes following mild cortical contusion. Glia 16, 266-275.
4. BASSO, M., GIRAUDO, S., CORPILLO, D., et al. (2004). Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 4, 3943-3952.
5. BOGAERT, Y.E., ROSENTHAL, R.E., and FISKUM, G. (1994). Postischemic inhibition of cerebral cortex pyruvate dehydrogenase. Free Radic. Biol. Med. 16, 811-820.
6. BOGAERT, Y.E., SHEU, K.F., HOF, P.R., et al. (2000). Neuronal subclass-selective loss of pyruvate dehydrogenase immunoreactivity following canine cardiac arrest and resuscitation. Exp. Neurol. 161, 115-126.
7. BRAUGHLER, J.M., and HALL, E.D. (1992). Involvement of lipid peroxidation in CNS injury. J. Neurotrauma 9, Suppl 1, SI-S7.
8. BROWN, M.R., SULLIVAN, P.G., DORENBOS, K.A., et al. (2004). Nitrogen disruption of synaptoneurosomes: an alternative method to isolate brain mitochondria. J. Neurosci. Methods 137, 299-303.
9. BUTTERFIELD, D.A. (2004). Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res. 1000, 1-7.
10. BUTTERFIELD, D.A., and LAUDERBACK, C.M. (2002). Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32, 1050-1060.
11. BUTTERFIELD, D.A., and CASTEGNA, A. (2003). Proteomic analysis of oxidatively modified proteins in Alzheimer's disease brain: insights into neurodegeneration. Cell Mol. Biol. (Noisy-le-Grand) 49, 747-751.
12. BUTTERFIELD, D.A., and BOYD-KIMBALL, D. (2004). Proteomics analysis in Alzheimer's disease: new insights into mechanisms of neurodegeneration. Int. Rev. Neurobiol. 61, 159-188.
13. BUTTERFIELD, D.A., BOYD-KIMBALL, D. and CASTEGNA, A. (2003). Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration. J. Neurochem. 86, 1313-1327.
14. CASTEGNA, A., AKSENOV, M., THONGBOONKERD, V., et al. (2002). Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J. Neurochem. 82, 1524-1532.
15. CASTEGNA, A., THONGBOONKERD, V., KLEIN, J.B., et al. (2003). Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 85, 1394-1401.
16. CASTEGNA, A., THONGBOONKERD, V., KLEIN, J., et al. (2004). Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins. J. Neurochem. 88, 1540-1546.
17. CHUANG, D.M., HOUGH, C., and SENATOROV, V.V. (2005). Glyceraldehyde-3- phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 45, 269-290.
18. COATES, P.J., JAMIESON, D.J., SMART, K., et al. (1997). The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr. Biol. 7, 607-610.
19. DE MEIRLEIR, L., LISSENS, W., DENIS, R., et al. (1993). Pyruvate dehydrogenase deficiency: clinical and biochemical diagnosis. Pediatr. Neurol. 9, 216-220.
20. DRAKE, J., SULTANA, B., AKSENOVA, M., et al. (2003). Elevation of mitochondrial glutathione by gamma-glutamyl-cysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. J. Neurosci. Res. 74, 917-927.
21. EATON, P., JONES, M.E., McGREGOR, E., et al. (2003). Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J. Am. Soc. Nephrol. 14, S290-S296.
22. FISKUM, G., STARKOV, A., POLSTER, B.M., et al. (2003). Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann. N. Y. Acad. Sci. 991, 111-119.
23. FISKUM, G., ROSENTHAL, R.E., VERECZKI, V., et al. (2004). Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. J. Bioenerg. Biomembr. 36(4): 347-352.
24. FRIBERG, H., and WIELOCH, T. (2002). Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84, 241-250.
25. GIBSON, G.E., and HUANG, H.M. (2004). Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases. J. Bioenerg. Biomembr. 36, 335-340.
26. GIBSON, G.E., ZHANG, H., SHEU, K.F., et al. (1998). Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation. Ann. Neurol. 44, 676-681.
27. GIEGE, P., HEAZLEWOOD, J.L., ROESSNER-TUNALI, U., et al. (2003). Enzymes of glycolysis are functionally associated with the mitochondrion in Arabidopsis cells. Plant Cell 15, 2140-2151.
28. HALL, E.D., KUPINA, N.C., and ALTHAUS, J.S. (1999). Peroxynitrite scavengers for the acute treatment of traumatic brain injury. Ann. N. Y. Acad. Sci. 890, 462-468.
29. HALL, E.D., SULLIVAN, P.G., GIBSON, T.R., et al. (2005). Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury. J. Neurotrauma 22, 252-265.
30. HARA, M.R., CASCIO, M.B., and SAWA. A. (2006). GAPDH as a sensor of NO stress. Biochim. Biophys. Acta 1762, 502-509.
31. HARD, M.L., RAHA, S., SPINO, M., et al. (2001). Impairment of pyruvate dehydrogenase activity by acetaldehyde. Alcohol 25, 1-8.
32. HARRIS, L.K., BLACK, R.T., GOLDEN, K.M., et al. (2001). Traumatic brain injury-induced changes in gene expression and functional activity of mitochondrial cytochrome c oxidase. J. Neurotrauma 18, 993-1009.
33. HENSLEY, K., HALL, N., SUBRAMANIAM, R., et al. (1995). Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
34. HOVDA, D.A., YOSHINO, A., KAWAMATA, T., et al. (1991). Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study. Brain Res. 567, 1-10.
35. HOVDA, D.A., BECKER, D.P., and KATAYAMA, Y. (1992). Secondary injury and acidosis. J. Neurotrauma 9, Suppl 1. S47-S60.
36. JIN, Y., McEWEN, M.L., NOTTINGHAM, S.A., et al. (2004). The mitochondrial uncoupling agent 2,4-dinitrophenol improves mitochondrial function, attenuates oxidative damage, and increases white matter sparing in the contused spinal cord. J. Neurotrauma 21, 1396-1404.
37. KADENBACH, B., ARNOLD, S., LEE, I., et al. (2004). The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochim. Biophys. Acta 1655, 400-408.
38. LAMANNA, J.C., HARIK, S.I., LIGHT, A.I., et al. (1981). Norepinephrine depletion alters cerebral oxidative metabolism in the "active" state. Brain Res. 204, 87-101.
39. LAUDERBACK, C.M., HACKETT, J.M., HUANG, F.F., et al. (2001). The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J. Neurochem. 78, 413-416.
40. LAVOIE, J., and BUTTERWORTH, R.F. (1995). Reduced activities of thiamine-dependent enzymes in brains of alcoholics in the absence of Wernicke's encephalopathy. Alcohol Clin. Exp. Res. 19, 1073-1077.
41. LEWEN, A., FUJIMURA, M., SUGAWARA, T., et al. (2001). Oxidative stress-dependent release of mitochondrial cytochrome c after traumatic brain injury. J. Cereb. Blood Flow Metab. 21, 914-920.
42. LEYVA, J.A., BIANCHET, M.A., and AMZEL, L.M. (2003). Understanding ATP synthesis: structure and mechanism of the F1-ATPase [Review]. Mol. Membr. Biol. 20, 27-33.
43. LIAUD, M.F., LICHTLE, C., APT, K., et al. (2000). Compartment-specific isoforms of TP1 and GAPDH are imported into diatom mitochondria as a fusion protein: evidence in favor of a mitochondrial origin of the eukaryotic glycolytic pathway. Mol. Biol. Evol. 17, 213-223.
44. LIFSHITZ, J., SULLIVAN, P.G., HOVDA, D.A., et al. (2004). Mitochondrial damage and dyfunction in traumatic brain injury. Mitochondria 1, 705-713.
45. LIU, X.H., QIAN, L.J., GONG, J.B., et al. (2004). Proteomic analysis of mitochondrial proteins in cardioniyocytes from chronic stressed rat. Proteomics 4, 3167-3176.
46. MARTIN, E., ROSENTHAL, R.E., and FISKUM, G. (2005). Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. J. Neurosci. Res. 79, 240-247.
47. MAURER, M.H., FELDMANN, R.E., JR., BROMME, J.O., et al. (2005). Comparison of statistical approaches for the analysis of proteome expression data of differentiating neural stem cells. J. Proteome Res. 4, 96-100.
48. McNAIR, N.D. (1999). Traumatic brain injury. Nurs. Clin. North Am. 34, 637-659.
49. MOHSEN, A.W., ANDERSON, B.D., VOLCHENBOUM, S.L., et al. (1998). Characterization of molecular defects in isovaleryl-CoA dehydrogenase in patients with isovaleric acidemia. Biochemistry 37, 10325-10335.
50. MOHSEN, A.W., NAVARETTE, B., and VOCKLEY, J. (2001). Identification of Caenorhabditis elegans isovaleryl-CoA dehydrogenase and structural comparison with other acyl-CoA dehydrogenases. Mol. Genet. Metab. 73, 126-137.
51. NICHOLLS, D.G., and BUDD, S.L. (2000). Mitochondria and neuronal survival. Physiol. Rev. 80, 315-360.
52. NICHOLLS, D.G., and FERGUSON, S.J. (2002). Bioenergetics3. Academic Press: London.
53. NIJTMANS, L.G., DE JONG, L., ARTAL SANZ, M., et al. (2000). Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 19, 2444-2451.
54. NIJTMANS, L.G., ARTAL, S.M., GRIVELL, L.A., et al. (2002). The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol. Life Sci. 59, 143-155.
55. POCERNICH, C.B., and BUTTERFIELD, D.A. (2003). Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox. Res. 5, 515-520.
56. POLLARD, P.J., WORTHAM, N.C., and TOMLINSON, I.P. (2003). The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. Ann. Med. 35, 632-639.
57. POON, H.F., CASTEGNA, A., FARR, S.A., et al. (2004). Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 126, 915-926.
58. POON, H.F., FARR, S.A., THONGBOONKERD, V., et al. (2005). Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem. Int. 46, 159-168.
59. REGO, A.C., and OLIVEIRA, C.R. (2003). Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem. Res. 28, 1563-1574.
60. ROSENTHAL, R.E., SILBERGLEIT, R., HOF, P.R., et al. (2003). Hyperbaric oxygen reduces neuronal death and improves neurological outcome after canine cardiac arrest. Stroke 34, 1311-1316.
61. SCHEFF, S.W., and SULLIVAN, P.G. (1999). Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J. Neurotrauma 16, 783-792.
62. SHEU, K.F., KIM, Y.T., BLASS, J.P., et al. (1985). An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann. Neurol. 17, 444-449.
63. SIMS, N.R. (1990). Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation. J. Neurochem. 55, 698-707.
64. SORBI, S., BIRD, E.D., and BLASS, J.P. (1983). Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann. Neurol. 13, 72-78.
65. SRIRAM, K., SHANKAR, S.K., BOYD, M.R., et al. (1998). Thiol oxidation and loss of mitochondrial complex I precede excitatory amino acid-mediated neurodegeneration. J. Neurosci. 18, 10287-10296.
66. STARKOV, A.A., FISKUM, G., CHINOPOULOS, C., et al. (2004). Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 24, 7779-7788.
67. SULLIVAN, P.G., KELLER, J.N., MATTSON, M.P., et al. (1998). Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function. J. Neurotrauma 15, 789-798.
68. SULLIVAN, P.G., THOMPSON, M.B., and SCHEFF, S.W. (1999). Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp. Neurol. 160, 226-234.
69. SULLIVAN, P.G., GEIGER, J.D., MATTSON, M.P., et al. (2000a). Dietary supplement creatine protects against traumatic brain injury. Ann. Neurol. 48, 723-729.
70. SULLIVAN, P.G., RABCHEVSKY, A.G., HICKS, R.R., et al. (2000b). Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 101, 289-295.
71. SULLIVAN, P.G., KELLER, J.N., BUSSEN, W.L., et al. (2002). Cytochrome c release and caspase activation after traumatic brain injury. Brain Res. 949, 88-96.
72. SULLIVAN, P.G., DUBE, C., DORENBOS, K.D., et al. (2003). Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann. Neurol. 53, 711-717.
73. SULLIVAN, P.G., RABCHEVSKY, A.G., KELLER, J.N., et al. (2004a). Intrinsic differences in brain and spinal cord mitochondria: implication for therapeutic interventions. J. Comp. Neurol. 474, 524-534.
74. SULLIVAN, P.G., RIPPY, N.A., DORENBOS, K., et al. (2004b). The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 55, 576-580.
75. SULLIVAN, P.G., RABCHEVSKY, A.G., WALDMEIER, P.C., et al. (2005). Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J. Neurosci. Res. 79, 231-239.
76. SULTANA, R., and BUTTERFIELD, D.A. (2004). Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products. Neurochem. Res. 29, 2215-2220.
77. SULTANA, R., BOYD-KIMBALL, D., POON, H.F., et al. (2006). Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis. Neurobiol. Aging 27, 918-925.
78. SZEWCZYK, A., and WOJTCZAK, L. (2002). Mitochondria as a pharmacological target. Pharmacol. Rev. 54, 101-127.
79. TABATABAIE, T., POTTS, J.D., and FLOYD, R.A. (1996). Reactive oxygen species-mediated inactivation of pyruvate dehydrogenase. Arch. Biochem. Biophys. 336, 290-296.
80. TAYLOR, S.W., FAHY, E., ZHANG, B., et al. (2003). Characterization of the human heart mitochondrial proteome. Nat. Biotechnol. 21, 281-286.
81. THONGBOONKERD, V., McLEISH, K.R., ARTHUR, J.M., et al. (2002). Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 62, 1461-1469.
82. TIBBS, R.E., JR., HAINES, D.E., and PARENT, A.D. (1998). The child as a projectile. Anat. Ree. 253, 167-175.
83. TUBOI, S., SUZUKI, T., SATO, M., et al. (1990). Rat liver mitochondrial and cytosolic fumarases with identical amino acid sequences are encoded from a single mRNA with two alternative in-phase AUG initiation sites. Adv. Enzyme Regul. 30, 289-304.
84. VANDER HEIDEN, M.G., CHANDEL, N.S., LI, X.X., et al. (2000). Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc. Natl. Acad. Sci. USA 97, 4666-4671.
85. VINK, R., HEAD, V.A., ROGERS, P.J., et al. (1990). Mitochondrial metabolism following traumatic brain injury in rats. J. Neurotrauma 7, 21-27.
86. VOLCHENBOUM, S.L., and VOCKLEY, J. (2000). Mitochondrial import and processing of wild type and type III mutant isovaleryl-CoA dehydrogenase. J. Biol. Chem. 275, 7958-7963.
87. WALLACE, D.C. (1999). Mitochondrial diseases in man and mouse. Science 283, 1482-1488.
88. WHARTON, D.C., and TZAGOLOFF, M. (1964). Studies on the electron transfer system LVII the near infrared absorption band of cytochrome oxidase. J. Biol. Chem. 239, 2036-2041.
89. XIONG, Y., GU, Q., PETERSON, P.L., et al. (1997). Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. J. Neurotrauma 14, 23-34.
90. YOO, B.C., FOUNTOULAKIS, M., CAIRNS, N., et al. (2001). Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome. Electrophoresis 22, 172-179.
91. ZAIDAN, E., SHEU, K.F., and SIMS, N.R. (1998). The pyruvate dehydrogenase complex is partially inactivated during early recirculation following short-term forebrain ischemia in rats. J. Neurochem. 70, 233-241.
92. ZHANG, X., CHEN, Y., JENKINS, L.W., et al. (2005). Bench-to-bedside review: apoptosis/programmed cell death triggered by traumatic brain injury. Crit. Care 9, 66-75.